Investors / Sanofi Ventures
Sanofi Ventures
Corporate VC
Sanofi Ventures is the corporate venture capital arm of Sanofi. It invests in biotech and digital health companies and offers portfolio companies access to Sanofi's expertise in science, development, regulatory, manufacturing, market access and commercialization.
Invests inHealthcare & Biotech
In its own wordsbiotechdigital healthrare diseasesimmunologyoncologycell and gene therapy
Your fit with Sanofi Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSanofi Ventures lists 75 checked portfolio companies on its own site and is named in 37 funding rounds, 11 of them as lead. Its most frequent entry is Series B, 46% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 78% of its companies are based in United States. It invests most often alongside RA Capital, Catalio Capital Management and Atlas Venture.
Counts come from funding rounds that name Sanofi Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Sanofi Ventures' whole history. Rounds on record name 33 companies; its own site lists 75. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 29% |
| Series B | 46% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 15 | 6 |
| '26 | 22 | 5 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 92th | 75 companies |
| Recent activity | 99th | 24 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 97th | 31% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 96th | 11 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 11 |
| Catalio Capital Management | 8 |
| Atlas Venture | 5 |
| F-Prime Capital | 5 |
| Forbion | 5 |
| Foresite Capital | 5 |
| NEA | 5 |
| 5AM Ventures | 4 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7093%
- No longer answers00%
- Points to another company57%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Sanofi Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Sanofi Ventures| Date | Company | Stage |
|---|---|---|
| 10 Nov 2026 | Series B | |
| 5 Nov 2026 | Series B | |
| 15 Oct 2026 | Series C+ | |
| 7 Oct 2026 | Series B | |
| 12 Aug 2026 | Series B | |
| 10 Aug 2026 | Series C+ | |
| 5 Aug 2026 | Series B | |
| 4 Aug 2026 | Series B |
Round details for Sanofi Ventures
Amounts, full round histories and every co-investor in Sanofi Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
75 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abcuro develops therapies for autoimmune diseases and cancer. | Healthcare & Biotech | Portfolio page | ||
| AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment. | Healthcare & Biotech | Jul 2026Series C+ | Page + round | |
| Datavant securely connects, protects, and activates health data across the healthcare ecosystem through a data collaboration platform | Healthcare & Biotech | Portfolio page | ||
| Altesa BioSciences is developing a medicine to treat rhinovirus infections in chronic lung diseases such as COPD and asthma | Healthcare & Biotech | Feb 2026Series B | Funding round | |
| Alveus Therapeutics develops treatments for obesity and weight loss maintenance | Healthcare & Biotech | Jan 2026Series A | Funding round | |
| Arexera Therapeutics pioneers CNS therapeutics by precisely targeting genetic disease drivers across the nervous system | Healthcare & Biotech | Portfolio page | ||
| Attovia Therapeutics is developing next-generation biotherapeutics for immune-mediated diseases. | Healthcare & Biotech | Apr 2025Series C+ | Page + round | |
| Avilar Therapeutics is developing novel degraders of extracellular proteins as future standard of care medicines for the treatment of multiple serious diseases. | Healthcare & Biotech | Portfolio page | ||
| Bionyra Pharma is a clinical-stage biopharmaceutical company developing antibody therapies for immune-mediated inflammatory diseases such as atopic dermatitis and inflammatory bowel disease. | Healthcare & Biotech | Jun 2026Series A | Page + round | |
Healthcare & Biotech | Portfolio page | |||
| BranchLab provides a semantic activation platform for healthcare commercialization | Healthcare & Biotech | May 2026Series A | Page + round | |
| Carbon Health provides primary and urgent care services, including virtual care and testing, to patients of all ages. | Healthcare & Biotech | Portfolio page | ||
| Character Bio is a clinical-stage biotechnology company developing new medicines for eye diseases | Healthcare & Biotech | Sept 2025Series B | Page + round | |
| Click Therapeutics develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| COUR Pharma develops targeted therapies for autoimmune diseases | Healthcare & Biotech | Jun 2026Series B | Funding round | |
| Diagonal Therapeutics develops clustering antibodies to correct the root cause of genetic diseases | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| Draig Therapeutics is developing therapies to treat neuropsychiatric disorders | Healthcare & Biotech | Jun 2025Series A | Page + round | |
| ELECTRA Therapeutics is developing therapies to improve outcomes for patients with immune-mediated diseases and cancer. | Healthcare & Biotech | Oct 2025Series C+ | Funding round | |
| Eligo Bioscience edits the microbiome gene repertoire in vivo | Healthcare & Biotech | Portfolio page | ||
| Empatica develops medical devices, AI and algorithms for remote patient monitoring | Healthcare & Biotech | Portfolio page |
About this data
site last read 11 Nov 2026- Site
- sanofiventures.com
- Last read
- 11 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 6 Jan 2025
- Companies checked
- 75
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sanofi Ventures' profile as data
Pull Sanofi Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sanofiventures.com
# also
GET /v1/firms/sanofiventures.com/portfolio
GET /v1/firms/sanofiventures.com/coinvestors
GET /v1/firms/sanofiventures.com/news